Literature DB >> 28781979

Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction.

Reyna L VanGilder1, Jason D Huber1.   

Abstract

Diabetes is a long-standing disease that leads to secondary complications of capillaries such as retinopathy, nephropathy and neuropathy. Emerging evidence suggests that diabetes may also affect the cerebromicrovasculature, the blood-brain barrier (BBB), and lead to changes in the brain that affect cognition and mood. Therefore, it is important to identify natural compounds that may have therapeutic benefit for reducing BBB dysfunction and improve patient quality of life. Preclinical evidence suggests that sesamol, a natural antioxidant in sesame seed oil, could have therapeutic benefit for treating BBB dysfunction during diabetes. Similarly, paroxetine, which shares a methylenedioxy moiety with sesamol shows clinical benefit for treating neuropathic pain associated with diabetes. This review emphasizes BBB dysfunction as a treatable secondary complication associated with diabetes and examines the evidence for the use of natural compounds like sesamol or existing therapies like paroxetine to help restore BBB function.

Entities:  

Keywords:  BBB dysfunction; blood-brain barrier; cognition; depression; diabetes; paroxetine; sesamol

Year:  2014        PMID: 28781979      PMCID: PMC5542572     

Source DB:  PubMed          Journal:  Postdoc J        ISSN: 2328-9791


  62 in total

1.  In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.

Authors:  L Jurd; V L Narayanan; K D Paull
Journal:  J Med Chem       Date:  1987-10       Impact factor: 7.446

2.  Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.

Authors:  R L VanGilder; K A Kelly; M D Chua; R L Ptachcinski; Jason D Huber
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

3.  Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-γ.

Authors:  Srinivasan Periasamy; Dur-Zong Hsu; Po-Cheng Chang; Ming-Yie Liu
Journal:  J Nutr Biochem       Date:  2013-12-01       Impact factor: 6.048

4.  Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.

Authors:  Leyla Gülseren; Seref Gülseren; Zeliha Hekimsoy; Levent Mete
Journal:  Arch Med Res       Date:  2005 Mar-Apr       Impact factor: 2.235

5.  Additive effects of hypertension and diabetes on renal cortical expression of PKC-alpha and -epsilon and alpha-tubulin but not PKC-beta 1 and -beta 2.

Authors:  Tanya M Osicka; Leileata M Russo; Mei-Lan Qiu; Gail C Brammar; Vicki Thallas; Josephine M Forbes; Wayne D Comper; George Jerums
Journal:  J Hypertens       Date:  2003-12       Impact factor: 4.844

6.  Free radical induced increase in protein carbonyl is attenuated by low dose of adenosine in hippocampus and mid brain: implication in neurodegenerative disorders.

Authors:  M S Parihar; M K Pandit
Journal:  Gen Physiol Biophys       Date:  2003-03       Impact factor: 1.512

7.  Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells.

Authors:  E A Mazzio; N Harris; K F Soliman
Journal:  Planta Med       Date:  1998-10       Impact factor: 3.352

8.  Teaching an old drug new tricks: can paroxetine ease the burden of cardiovascular disease in diabetes?

Authors:  Stephen B Wheatcroft
Journal:  Diabetes       Date:  2013-03       Impact factor: 9.461

9.  Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission.

Authors:  Youichi Shinozaki; Masatoshi Nomura; Ken Iwatsuki; Yoshinori Moriyama; Christian Gachet; Schuichi Koizumi
Journal:  Sci Rep       Date:  2014-03-10       Impact factor: 4.379

10.  The ameliorative effects of sesamol against seizures, cognitive impairment and oxidative stress in the experimental model of epilepsy.

Authors:  Parichehr Hassanzadeh; Elham Arbabi; Fatemeh Rostami
Journal:  Iran J Basic Med Sci       Date:  2014-02       Impact factor: 2.699

View more
  1 in total

1.  Sesamol prevents mitochondrial impairment and pro-inflammatory alterations in the human neuroblastoma SH-SY5Y cells: role for Nrf2.

Authors:  Sônia Mendes da Silva Navarro; Fhelipe Jolner Souza de Almeida; Matheus Dargesso Luckachaki; Marcos Roberto de Oliveira
Journal:  Metab Brain Dis       Date:  2022-01-09       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.